Toxicity and metabolism of layered double hydroxide intercalated with levodopa in a Parkinson's disease model
Layered hydroxide nanoparticles are generally biocompatible, and less toxic than most inorganic nanoparticles, making them an acceptable alternative drug delivery system. Due to growing concern over animal welfare and the expense of in vivo experiments both the public and the government are interest...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Published: |
MDPI AG
2014
|
| _version_ | 1796972797921067008 |
|---|---|
| author | Kura, Aminu Umar Mohd Ain, Nooraini Hussein, Mohd Zobir Fakurazi, Sharida Hussein-Al-Ali, Samer Hasan |
| author_facet | Kura, Aminu Umar Mohd Ain, Nooraini Hussein, Mohd Zobir Fakurazi, Sharida Hussein-Al-Ali, Samer Hasan |
| author_sort | Kura, Aminu Umar |
| collection | UPM |
| description | Layered hydroxide nanoparticles are generally biocompatible, and less toxic than most inorganic nanoparticles, making them an acceptable alternative drug delivery system. Due to growing concern over animal welfare and the expense of in vivo experiments both the public and the government are interested to find alternatives to animal testing. The toxicity potential of zinc aluminum layered hydroxide (ZAL) nanocomposite containing anti-Parkinsonian agent may be determined using a PC 12 cell model. ZAL nanocomposite demonstrated a decreased cytotoxic effect when compared to levodopa on PC12 cells with more than 80% cell viability at 100 µg/mL compared to less than 20% cell viability in a direct levodopa exposure. Neither levodopa-loaded nanocomposite nor the un-intercalated nanocomposite disturbed the cytoskeletal structure of the neurogenic cells at their IC50 concentration. Levodopa metabolite (HVA) released from the nanocomposite demonstrated the slow sustained and controlled release character of layered hydroxide nanoparticles unlike the burst uptake and release system shown with pure levodopa treatment. |
| first_indexed | 2024-03-06T08:33:39Z |
| format | Article |
| id | upm.eprints-35877 |
| institution | Universiti Putra Malaysia |
| last_indexed | 2024-03-06T08:33:39Z |
| publishDate | 2014 |
| publisher | MDPI AG |
| record_format | dspace |
| spelling | upm.eprints-358772016-02-11T04:38:54Z http://psasir.upm.edu.my/id/eprint/35877/ Toxicity and metabolism of layered double hydroxide intercalated with levodopa in a Parkinson's disease model Kura, Aminu Umar Mohd Ain, Nooraini Hussein, Mohd Zobir Fakurazi, Sharida Hussein-Al-Ali, Samer Hasan Layered hydroxide nanoparticles are generally biocompatible, and less toxic than most inorganic nanoparticles, making them an acceptable alternative drug delivery system. Due to growing concern over animal welfare and the expense of in vivo experiments both the public and the government are interested to find alternatives to animal testing. The toxicity potential of zinc aluminum layered hydroxide (ZAL) nanocomposite containing anti-Parkinsonian agent may be determined using a PC 12 cell model. ZAL nanocomposite demonstrated a decreased cytotoxic effect when compared to levodopa on PC12 cells with more than 80% cell viability at 100 µg/mL compared to less than 20% cell viability in a direct levodopa exposure. Neither levodopa-loaded nanocomposite nor the un-intercalated nanocomposite disturbed the cytoskeletal structure of the neurogenic cells at their IC50 concentration. Levodopa metabolite (HVA) released from the nanocomposite demonstrated the slow sustained and controlled release character of layered hydroxide nanoparticles unlike the burst uptake and release system shown with pure levodopa treatment. MDPI AG 2014 Article PeerReviewed Kura, Aminu Umar and Mohd Ain, Nooraini and Hussein, Mohd Zobir and Fakurazi, Sharida and Hussein-Al-Ali, Samer Hasan (2014) Toxicity and metabolism of layered double hydroxide intercalated with levodopa in a Parkinson's disease model. International Journal of Molecular Sciences, 15 (4). pp. 5916-5927. ISSN 1422-0067 http://www.mdpi.com/1422-0067/15/4/5916 10.3390/ijms15045916 |
| spellingShingle | Kura, Aminu Umar Mohd Ain, Nooraini Hussein, Mohd Zobir Fakurazi, Sharida Hussein-Al-Ali, Samer Hasan Toxicity and metabolism of layered double hydroxide intercalated with levodopa in a Parkinson's disease model |
| title | Toxicity and metabolism of layered double hydroxide intercalated with levodopa in a Parkinson's disease model |
| title_full | Toxicity and metabolism of layered double hydroxide intercalated with levodopa in a Parkinson's disease model |
| title_fullStr | Toxicity and metabolism of layered double hydroxide intercalated with levodopa in a Parkinson's disease model |
| title_full_unstemmed | Toxicity and metabolism of layered double hydroxide intercalated with levodopa in a Parkinson's disease model |
| title_short | Toxicity and metabolism of layered double hydroxide intercalated with levodopa in a Parkinson's disease model |
| title_sort | toxicity and metabolism of layered double hydroxide intercalated with levodopa in a parkinson s disease model |
| work_keys_str_mv | AT kuraaminuumar toxicityandmetabolismoflayereddoublehydroxideintercalatedwithlevodopainaparkinsonsdiseasemodel AT mohdainnooraini toxicityandmetabolismoflayereddoublehydroxideintercalatedwithlevodopainaparkinsonsdiseasemodel AT husseinmohdzobir toxicityandmetabolismoflayereddoublehydroxideintercalatedwithlevodopainaparkinsonsdiseasemodel AT fakurazisharida toxicityandmetabolismoflayereddoublehydroxideintercalatedwithlevodopainaparkinsonsdiseasemodel AT husseinalalisamerhasan toxicityandmetabolismoflayereddoublehydroxideintercalatedwithlevodopainaparkinsonsdiseasemodel |